MyBacteriophage

MyBacteriophage is an innovative biotechnology company focused on developing personalized bacteriophage therapies to combat the global threat of antibiotic-resistant bacterial infections. The company utilizes a proprietary platform to identify, isolate, and characterize specific phages that target a patient's unique bacterial strain, offering a highly precise alternative to traditional broad-spectrum antibiotics. By leveraging advanced genomic sequencing and rapid screening technologies, MyBacteriophage aims to provide tailored treatments for chronic and life-threatening infections. Their approach focuses on high-need areas such as cystic fibrosis, prosthetic joint infections, and multi-drug resistant wound infections.